Nephrotoxicity of CyA was analyzed histologically in rats fed a low-sodium diet. CyA was subcutaneously administered daily at a dose of 15 mg/kg for 10 or 35 days with or without prior uninephrectomy (UNT) in male Sprague-Dawley rats receiving a low-sodium diet (0.03% sodium). CyA-administered rats showed impaired renal function as well as tubulo-interstitial lesions, such as edema, tubular basement membrane changes, and tubular atrophy, in the cortex, especially in the subcapsular portion, within 10 days. On day 35, the tubulo-interstitial lesions were advanced with mild focal interstitial fibrosis. These lesions were mild in the UNT group compared to the non-UNT group. Immunohistochemically, CyA treatment caused an increase in number of renin-positive cells in the afferent arteriolar wall at juxtaglomerular area. These cells lost the expression of calponin, which is a marker of mature smooth muscle cells. In addition, in afferent arterioles and interlobular arteries, electron-dense fibrous bodies were found in the smooth muscle cells on days 10 and 35. Immunoelectron microscopically, these bodies showed scattered positive staining for calponin and α-actinin, were negative or only peripherally positive for α-SMA and vimentin, and were completely negative for desmin. This study revealed that CyA could cause interstitial lesions starting in the subcapsular portion of the renal cortex and vascular lesions of the preglomerular artery. Increases in number of renin granules and formation of cytoplasmic fibrous bodies in smooth muscle cells could be the forerunner of severe arteriolar wall damage.
Andoh TF, Lam TT, Lindsley J., Alpers CE, Bennett WM (1997). Enhancement of chronic cyclosporine nephrotoxicity by sodium depletion in an experimental mouse model. Nephrology3: 471-478.
2.
Barajas L. (1979). Anatomy of the juxtaglomerular apparatus (editorial review). Am J Physiol237: F333-F343.
3.
Border WA, Noble NA (1994). Transforming growth factor β in tissue fibrosis . N Engl J Med331: 1286-1292.
4.
Cattell V. (1994). Macrophages in acute glomerular inflammation (editorial review). Kidney Int45: 945-952.
5.
Cavarape A., Endlich K., Feletto F., Parekh N., Bartoli E., Steinhausen M. (1998). Contribution of endothelin receptors in renal microvessels in acute cyclosporine-mediated vasoconstriction in rats. Kidney Int53: 963-969.
6.
Elzinga LW, Rosen S., Bennett WM (1993). Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: Role of sodium intake. J Am Soc Nephrol4: 214-221.
7.
English J.Evan A.Houghton DC, Bennett WM (1987). Cyclosporine-induced acute renal dysfunction in the rat. Transplantation44: 135-141.
8.
Fasel J., Kaissling B. Ludwig KS, Ryffel B., Mihatsch MJ (1987). Light and electron microscopic changes in the kidney of Wistar rats following treatment with cyclosporine A. Ultrastruct Pathol11: 435-448.
9.
Fried TA, Hishida A., Barnes JL, Stein JH (1984). Ischemic acute renal failure in the rat: Protective effect of uninephrectomy. Am J Physiol247: F568-F574.
10.
Ghiggeri GM , Altieri P., Oleggini R., Valenti F., Ginevri F., Perfumo F., Gusmano R. (1994). Cyclosporine enhances the synthesis of selected extracellular matrix proteins by renal cells "in culture." Transplantation57: 1382-1388.
11.
Gimona M., Herzog M., Vandekerckhove J., Small JV (1990). Smooth muscle specific expression of calponin . FEBS Lett274: 159-162.
12.
Kato A., Hishida A., Tanaka I., Komatsu K. (1997). Uninephrectomy prevents the ischemia-induced increase in renin activity. Nephron75: 72-76.
13.
Kimura K., Nagai R., Sakai T., et al (14 coauthors) (1995). Diversity and variability of smooth muscle phenotypes of renal arterioles as revealed by myosin isoform expression. Kidney Int48: 372-382.
14.
Kokui K., Yoshikawa N., Nakamura H., Itoh H. ( 1992). Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis. J Pathol166: 297-301.
15.
Kon V., Hunley TE, Fogo A. ( 1995). Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Transplantation60: 89-95.
16.
Lee Dbn (1997). Cyclosporine and the renin-angiotensin axis. Kidney Int52: 248-260.
17.
Liu A., Ballermann BJ (1998). TGF-β type II receptor in rat renal vascular development: Localization to juxtaglomerular cells. Kidney Int53: 716-725.
18.
Martin A., Wong K-S., Li M., Turner SW, Whitworth JA (1994). Cyclosporin hypertension in the wistar rat: Role of uninephrectomy. Clin Exp Pharmacol Physiol21: 287-292.
19.
Mason J., Müller-Schweinitzer E., Dupont M., Casellas D., Mihatsch M., Moore L., Kaskel F. (1991). Cyclosporine and the renin-angiotensin system . Kidney Int39: S28-S32.
20.
Medina J., Cordier A., Wolf A. ( 1997). Cyclosporine A-induced contraction of isolated rat aortic smooth muscle cells. Life Sci61: PL327-PL332.
21.
Mihatsch MJ , Thiel G., Spichtin HP, Oberholzer M., Brunner FP, Harder F., Olivieri V., Bremer R., Ryffel B., Stöcklin E., Torhorst J., Gudat F., Zollinger HU, Loertscher R. (1983). Morphological findings in kidney transplants after treatment with cyclosporine . Transplant Proc15(suppl 1): 2821-2835.
22.
Myers BD, Sibley R., Newton L., Tomlanovich SJ, Boshkos C., Stinson E., Luetscher JA, Whitney DJ, Krasny D., Coplon NS, Perlroth MG (1988). The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int33: 590-600.
23.
Niaudet P. (1995). Cyclosporine in the treatment of idiopathic nephrosis . Indian Pediatr32: 1317-1321.
24.
North AJ, Gimona M., Cross RA, Small JV (1994). Calponin is localised in both the contractile apparatus and the cytoskeleton of smooth muscle cells. J Cell Sci107: 437-444.
25.
Pimentel JL Jr, Sundell CL, Wang S., Kopp JB, Montero A., Martinez-Maldonado M. (1995 ). Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy. Kidney Int48: 1233-1246.
26.
Ponticelli C., Rizzoni G., Edefonti A., Altieri P., Rivolta E., Rinaldi S., Ghio L., Lusvarghi E., Gusmano R., Locatelli F. Pasquali S, Castellani A., Casa-Alberighi OD (1993). A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int43: 1377-1384.
27.
Rolls KA, Phillips PA. Aldred K., Hardy KJ (1994). Vasoconstrictor responses to components of the renin-angiotensin system in cyclosporin-induced hypertension in the rat. Clin Exp Pharmacol Physiol21: 227-230.
28.
Rosen S., Greenfeld Z., Brezis M. (1990). Chronic cyclosporine-induced nephropathy in the rat. Transplantation49: 445-452.
29.
Roullet J-B. , Xue H., McCarron DA, Holcomb S., Bennett WM (1994). Vascular mechanisms of cyclosporin-induced hypertension in the rat. J Clin Invest93: 2244-2250.
30.
Ryffel B., Siegl H., Petric R., Muller AM, Hauser R., Mihatsch MJ (1986). Nephrotoxicity of cyclosporine in spontaneously hypertensive rats: Effects on blood pressure and vascular lesions. Clin Nephrol25(suppl 1): S193-S198.
31.
Seppo T., Tero S., Tapio N. (1989). Ultrastructural, immunochemical and electrophoretic study of smooth muscle cells in internal mammary arteries of patients undergoing coronary bypass surgery. Atherosclerosis79: 129-138.
32.
Shanley PF (1996). The pathology of chronic renal ischemia. Semin Nephrol16: 21-32.
33.
Shehata M., Cope GH, Johnson TS, Raftery AT, El Nahas AM (1995). Cyclosporine enhances the expression of TGF-β in the juxtaglomerular cells of the rat kidney. Kidney Int48: 1487-1496.
Strϕm EH, Epper R., Mihatsch MJ (1995). Ciclosporin-associated arteriolopathy: The renin producing vascular smooth muscle cells are more sensitive to ciclosporin toxicity. Clin Nephrol43: 226-231.
38.
Stromer MH (1995). Immunocytochemistry of the muscle cell cytoskeleton . Microsc Res Tech31: 95-105.
39.
Vernetti LA , Gandolfi AJ, Nagle RB (1991). Selective alteration of cytokeratin intermediate filament by cyclosporine A is a lethal toxicity in PtK2 cell cultures. Adv Exp Med Biol283: 847-851.
40.
von Graffenried B., Friend D., Shand N., Schiess W., Timonen P. (1989). Cyclosporin A (Sandimmun®) in autoimmune disorders . In: Cyclosporin, Thomson AW (ed). Kluwer Academic, Dordrecht, pp 213-251.
41.
Young BA, Burdmann EA, Johnson RJ, Alpers CE, Giachelli CM, Eng E., Andoh T., Bennett WM, Couser WG (1995). Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int48: 439-448.
42.
Young BA, Burdmann EA, Johnson RJ, Andoh T., Bennett WM, Couser WG, Alpers CE (1995). Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy. Kidney Int48: 431-438.
43.
Zoja C., Furci L., Ghilardi F., Zilio P., Benigni A., Remuzzi G. (1986). Cyclosporin-induced endothelial cell injury. Lab Invest55: 455-462.
